Irisin in idiopathic foetal growth restriction

dc.contributor.authorCaglar, Mete
dc.contributor.authorGoksu, Mehmet
dc.contributor.authorIsenlik, Bekir Sitki
dc.contributor.authorYavuzcan, Ali
dc.contributor.authorYilmaz, Musa
dc.contributor.authorUstun, Yusuf
dc.contributor.authorKumru, Selahattin
dc.date.accessioned2026-08-12T17:32:09Z
dc.date.issued2014
dc.departmentFırat Üniversitesi
dc.description.abstractPurpose The aim of the present study was to compare maternal serum and cord blood irisin levels in females whose pregnancies were or were not complicated by idiopathic foetal growth restriction. Methods A total of 30 subjects participated. The study group consisted of 15 female patients who were referred to our perinatology clinic for delivery because of foetal growth restriction developing in the third trimester. Fifteen females with uncomplicated singleton pregnancies constituted the control group. Irisin levels were assessed in maternal serum, as well as in serum from the umbilical vein and artery. Results The demographic features of the two groups were similar (p > 0.05). Gestational age at delivery and birth weight were higher in females with uncomplicated pregnancies (p = 0.001). Umbilical artery irisin levels were significantly lower in pregnancies complicated by foetal growth restriction compared to controls (p = 0.003). Umbilical artery irisin levels were positively correlated with foetal weight (p = 0.01) and foetal abdominal circumference (measured by ultrasonography) (p = 0.01). Maternal and umbilical vein irisin levels did not differ between the two groups (p > 0.05). Conclusions The data suggest that umbilical artery irisin levels were lower in pregnancies complicated by foetal growth restriction. Such lower irisin levels may contribute to the pathogenesis of this common condition, and metabolic syndrome may be a long-term consequence of idiopathic FGR.
dc.identifier.doi10.1007/s40618-014-0078-5
dc.identifier.endpage624
dc.identifier.issn0391-4097
dc.identifier.issn1720-8386
dc.identifier.issue7
dc.identifier.orcid0000-0002-1926-4044
dc.identifier.orcid0000-0001-9557-678X
dc.identifier.pmid24789538
dc.identifier.scopus2-s2.0-84898965439
dc.identifier.scopusqualityQ1
dc.identifier.startpage619
dc.identifier.urihttps://doi.org/10.1007/s40618-014-0078-5
dc.identifier.urihttps://hdl.handle.net/11508/56536
dc.identifier.volume37
dc.identifier.wosWOS:000338541200003
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofJournal of Endocrinological Investigation
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subjectFoetal growth restriction
dc.subjectFat mass
dc.subjectIrisin
dc.subjectLean mass
dc.subjectMetabolic syndrome
dc.subjectUmbilical artery
dc.titleIrisin in idiopathic foetal growth restriction
dc.typeArticle

Dosyalar